Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2011
03/03/2011WO2011022921A1 Reactor-type rapid measuring instrument for biochemical oxygen demand (bod) and measurement method thereof
03/03/2011WO2011022895A1 Rapid measurement method for biochemical oxygen demand (bod) by using saccharomyces cerevisiae as biological recognition elements
03/03/2011WO2011022844A1 Gas monitoring system
03/03/2011WO2011022824A1 Rapid multi-component optical protein patterning by photobleaching
03/03/2011WO2011022820A1 Binding-induced hairpin detection system
03/03/2011WO2011022805A1 Novel colchicine derivatives, methods and uses thereof
03/03/2011WO2011022780A1 Methods for the diagnosis and prognosis of autoimmune disease
03/03/2011WO2011005357A3 Immunogenicity assay
03/03/2011WO2011000572A4 Method and device for detecting long-term biological effects in cells
03/03/2011WO2011000486A3 Method for obtaining electrical energy from the kinetic energy of waves
03/03/2011WO2010150901A9 Mutant for increasing oleic acid content of soybean oil and fat, and responsible gene therefor
03/03/2011WO2010146592A3 Method for the diagnosis of pathological conditions in animals
03/03/2011WO2010146041A3 Method for determining the suitability of a renewable fuel for combustion in a compression ignition engine
03/03/2011WO2010144747A3 Flexible pouch and cartridge with fluidic circuits
03/03/2011WO2010142906A3 Protein antigens for the serodiagnosis of staphylococcus aureus infections, in particular on osteoarticular prostheses
03/03/2011WO2010141563A3 A closed in-line apparatus and method for fluid aspiration
03/03/2011WO2010141365A3 Integrated optofluidic system using microspheres
03/03/2011WO2010140779A3 Sampling/sample-injecting apparatus and biodata-measuring set comprising same
03/03/2011WO2010139863A9 Method for antibody immobilization
03/03/2011WO2010138839A3 Use of 2 anti-sparc antibodies to predict response to chemotherapy
03/03/2011WO2010137903A3 Method for screening for a drug candidate substance which inhibits target protein-protein interaction for developing a novel concept drug
03/03/2011WO2010137807A3 Method for signal amplification during lateral-flow analysis
03/03/2011WO2010133806A3 Marked peptides and use thereof for assaying circulating irap
03/03/2011WO2010132486A3 Methods for the diagnosis of oncological disorders using epimetabolic shifters, multidimensional intracellular molecules, or environmental influencers
03/03/2011WO2010132447A3 Methods for detecting pre-diabetes and diabetes using differential protein glycosylation
03/03/2011WO2010129283A3 Microfluidic analyte capture using a thermoflowable material
03/03/2011WO2010129265A3 Compositions comprising monomeric streptavidin and methods for using same
03/03/2011WO2010129027A3 Analysis of membrane component interactions
03/03/2011WO2010127252A3 Monoclonal antibodies to influenza h1n1 virus and uses thereof
03/03/2011WO2010124227A3 Methods and devices for capturing circulating tumor cells
03/03/2011WO2010124226A3 Toll-like receptor-based biosensors
03/03/2011WO2010121023A3 Peptides and aptamers for targeting of neuron or nerves
03/03/2011WO2010120501A3 Assys for bacterial detection and identification
03/03/2011WO2010118347A3 O-linked glycan biosynthesis modulators
03/03/2011WO2010115092A3 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer
03/03/2011WO2010115089A3 Serial multiple antigen colocalization in paraffin-embedded tissue
03/03/2011WO2010115001A3 Rapid quantification assay involving concentrated and ligand-coated gold colloid
03/03/2011WO2010111388A3 Devices and methods of cell capture and analysis
03/03/2011WO2010104981A4 Deuterium isobaric tag reagents for quantitative analysis
03/03/2011WO2010101793A3 Methods and compositions for the diagnosis, prognosis and treatment of cancer
03/03/2011WO2010098613A9 Tm7sf3 composition for diagnosing liver cancer, diagnostic kit containing anti-tm7sf3 antibodies, and pharmaceutical composition for preventing or treating liver cancer
03/03/2011WO2010093222A3 Nucleic acid aptamer which specifically binds to bisphenol a
03/03/2011WO2010062935A3 Nanoparticulate cell culture surface
03/03/2011WO2010052543A8 Method for identification, selection and analysis of tumour cells
03/03/2011WO2010039189A3 Methods for sequencing degraded or modified nucleic acids
03/03/2011WO2007090076A8 Methods for identifying patients with an increased likelihood of having ovarian cancer and compositions therefor
03/03/2011US20110055943 Novel therapeutic targets in inflammatory bowel disease
03/03/2011US20110055942 Single domain TDF-related compounds and analogs thereof
03/03/2011US20110055941 Chd5 is a novel tumor suppressor gene
03/03/2011US20110055938 Transgenic animal for production of antibodies having minimal cdrs
03/03/2011US20110055937 Keratin 8 Mutations are Risk Factors for Developing Liver Disease of Multiple Etiologies
03/03/2011US20110055936 Transgenic mamals modifield in bri protein expression
03/03/2011US20110054938 Devices and methods for detecting an analyte in salivary fluid
03/03/2011US20110054932 System for Improving Antibiotic Use in Acute Care Hospitals
03/03/2011US20110054800 Sample processing system, method for saving electricity consumed by sample processing system, and non-transitory storage medium
03/03/2011US20110054284 Anti-Coagulant Calibrant Infusion Fluid Source
03/03/2011US20110054165 Xanthene dyes
03/03/2011US20110054159 Rna interference mediating small rna molecules
03/03/2011US20110054158 Polynucleotides encoding class ii cytokine receptor-7
03/03/2011US20110054148 Antibodies to interferon-like protein zcyto21(il-29)
03/03/2011US20110054009 MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders
03/03/2011US20110053994 Potent immunosuppressive agents, derivatives and uses
03/03/2011US20110053882 Methods and compounds for preventing and treating a tumour
03/03/2011US20110053880 Composition for treatment of tuberculosis
03/03/2011US20110053850 Doc1 compositions and methods for treating cancer
03/03/2011US20110053831 Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ards) and clinical disorders associated with therewith
03/03/2011US20110053828 Use of Urea-Adjuvated Polypeptides for Diagnosis, Prophylaxis and Therapy
03/03/2011US20110053791 Method for detecting or determining abnormal prion protein associated with transmissible spongiform encephalopathy in blood-derived specimen or body fluid-derived specimen
03/03/2011US20110053787 Compositions and Methods of Detecting Post-Stop Peptides
03/03/2011US20110053784 Microfluidic Device and Methods of Using Same
03/03/2011US20110053781 Methods and compositions for polypeptide engineering
03/03/2011US20110053292 signal amplification technique for mass analysis
03/03/2011US20110053291 Method for analyzing sample solution and apparatus for analyzing sample solution
03/03/2011US20110053290 Light addressing biosensor chip and method of driving the same
03/03/2011US20110053289 Assay Device and Method
03/03/2011US20110053283 Beverage Immersate with detection capability
03/03/2011US20110053282 Methods and Kits Using Extended Rhodamine Dyes
03/03/2011US20110053281 Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
03/03/2011US20110053280 Detection of Post-Translationally Modified Peptides with Liquid Crystals
03/03/2011US20110053279 Detection methods of proteins on polyacrylamide gels using gel background staining and organic dye compositions for the same
03/03/2011US20110053276 Molecular indicator and process of synthesizing
03/03/2011US20110053268 Method for diagnosis of abnormal iron metabolism using active hepcidin as indicator
03/03/2011US20110053243 Asymmetrically branched polymer conjugates and microarray assays
03/03/2011US20110053242 Immunoaffinity isolation of modified peptides from complex mixtures
03/03/2011US20110053220 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same
03/03/2011US20110053217 Polynucleotides encoding signal peptide-containing molecules
03/03/2011US20110053202 Analytical system, analytical method and flow-path structure
03/03/2011US20110053191 Method for risk reduction in glycemic control
03/03/2011US20110053190 Use of CFH or ApoH as a Biochemical Diagnostic Marker for Complete Remission in Acute Myeloid Leukemia
03/03/2011US20110053189 Type IV secretion system proteins in sero-detection of Anaplasma phagocytophium
03/03/2011US20110053188 Endotoxin detection method
03/03/2011US20110053187 Silica-based material for detection and isolation of chitin and chitin-containing microorganisms
03/03/2011US20110053186 Chlorite in the Treatment of Neurodegenerative Disease
03/03/2011US20110053185 Culture based screening assay and methods of use thereof to identify agents which modulate tumor development, invasion and differentiation
03/03/2011US20110053184 Nucleic Acid Encoding A Haplotype of Human T2R Receptor hT2R50
03/03/2011US20110053183 Method of concentrating human mesenchymal stem cells
03/03/2011US20110053182 Diagnosis of pre-cancerous conditions using pcdgf agents
03/03/2011US20110053181 Method for detecting objective substance and kit for detecting objective substance
03/03/2011US20110053180 Kinase sensors
03/03/2011US20110053179 Biomarkers For Prediction Of Major Adverse Cardiac Events And Uses Thereof